S-1/A: Natures Miracle Holding Inc. Files Amendment No. 2 to S-1 Registration for Unit and Share Offering

Natures Miracle Holding Inc. is amending its S-1 registration statement for a proposed offering of units, pre-funded units, and shares of common stock, including those for resale by selling stockholders.

Summary

• Natures Miracle Holding Inc. filed an amendment to its S-1 registration statement with the SEC on October 28, 2024.
• The registration covers the offering of up to 29,032,258 units, each consisting of one share of common stock, one Series A warrant, and one Series B warrant.
• The company is also offering up to 29,032,258 pre-funded units, each consisting of one pre-funded warrant, one Series A warrant, and one Series B warrant.
• Additionally, the registration includes 3,317,400 shares of common stock for resale by certain selling stockholders, including 2,924,150 outstanding shares and 393,250 shares issuable upon exercise of outstanding warrants.
• The company intends to use the proceeds from the offering for general corporate purposes, including working capital and investments.
• The assumed public offering price is $0.155 per unit, based on the closing price of the company's common stock on October 24, 2024.
• The Series A warrants will have an exercise price of $0.155 per share, and the Series B warrants will have an exercise price of $0.0001 per share.
• The number of shares issuable under the Series B warrants will be determined after the 10th trading day following warrant stockholder approval, based on 80% of the lowest daily average trading price, with a minimum price of $0.031 per share.
• The company's common stock is listed on The Nasdaq Global Market under the symbol NMHI.
• The company is an emerging growth company and has elected to comply with certain reduced public company reporting requirements.

Sentiment

Score: 4

Explanation: The document outlines a potential capital raise but also highlights significant risks and uncertainties, including going concern issues and potential delisting from Nasdaq. The sentiment is therefore cautiously negative.

Positives

• The company intends to use the net proceeds from the sale of our securities by us in this offering for general corporate purposes, including working capital and investments.

Negatives

• There is no established public trading market for the Units, Pre-Funded Units, Warrants or Pre-Funded Warrants being offered in this offering, and we do not expect markets to develop for these securities.
• The Warrants may not be exercised until we receive the Warrant Stockholder Approval. Under Nasdaq listing rules, the Warrants may not be exercised unless and until we obtain the Warrant Stockholder Approval. While we intend to promptly seek stockholder approval, there is no guarantee that the Warrant Stockholder Approval will ever be obtained. If we are unable to obtain the Warrant Stockholder Approval, the Warrants will have substantially less value.

Risks

• The company has incurred substantial operating losses since 2022 and there is substantial doubt about our ability to continue as a going concern.
• The company's stock price may fluctuate significantly.
• The company may not be able to continue to satisfy listing requirements of Nasdaq to maintain a listing of our common stock.
• Purchasers of our common stock in this offering will experience an immediate and substantial dilution in the net tangible book value per share of the common stock included in the Units.

Future Outlook

The company intends to use the net proceeds from the offering for general corporate purposes, including working capital and investments.

Industry Context

The company operates in the agriculture technology sector, providing Controlled Environment Agriculture (CEA) hardware products to growers in North America. The industry is driven by the increasing adoption of advanced agricultural technologies to improve productivity and operations.

Stakeholder Impact

• Shareholders may experience dilution as a result of this and future equity offerings.
• The company's ability to raise capital may be impaired if it is delisted from Nasdaq.

Next Steps

• The company intends to submit a hearing request to the Nasdaq Hearings Panel to appeal the Staff's delisting determination.
• The company intends to present a plan to regain compliance with the Nasdaq Listing Rules.
• The company intends to promptly seek stockholder approval for the warrants.

Key Dates

Keywords

Units, Pre-Funded Units, Common Stock, Warrants, Offering, Resale, Registration, NMHI, Natures Miracle, Securities